Metraipolis › archive › dc_250d710ab449

Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety — Europe PMC PMID:41598573

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41598573
DOI
10.3390/jcm15020634
License (as archived)
solo-consultazione
Archived
2026-11-06T20:26:00.557Z
SHA-256 of the archived text
52d61389419c1214540a31d54f3aae6c7d65d552c5ec946db043e3649b7b941f
Stable URL of this page
https://metraipolis.com/documento/dc_250d710ab449

How to cite

Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety — Europe PMC PMID:41598573 — Europe PMC (en), https://europepmc.org/article/MED/41598573 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_250d710ab449 (Metraipolis archive dc_250d710ab449, sha256 52d61389419c1214540a31d54f3aae6c7d65d552c5ec946db043e3649b7b941f)
BibTeX
@misc{dc250d710ab449,
  title = {Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety — Europe PMC PMID:41598573},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598573},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_250d710ab449; sha256 52d61389419c1214540a31d54f3aae6c7d65d552c5ec946db043e3649b7b941f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598573. Agents can read the archived copy with the MCP tool read_document.